NULOJIX
( belatacept )
Used to prevent transplant rejection in adults who have received kidney transplant
Kidney transplant patients have been on a long journey, and the risk of kidney rejection is ever-present. Material dealing with Nulojix to prevent kidney rejection needs to contain the right mix of education, instruction, inspiration and hope.
From patient treatment guides to research statistics and patient expectation for HCPs, Nulojix’s 360 approach keeps all involved, aware, and informed to the best of their abilities.
HCP materials were distributed throughout hospital, retail, and online pharmacies, and also utilized by end-users such as hospitals, specialty clinics, and transplant centers.